Cargando…
CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo
Current strategies for glioma treatment are only partly effective because of the poor selectivity for tumoral cells. Hence, the necessity to identify novel approaches is urgent. Recent studies highlighted the effectiveness of the bacterial protein cytotoxic necrotizing factor 1 (CNF1) in reducing tu...
Autores principales: | Vannini, Eleonora, Mori, Elisabetta, Tantillo, Elena, Schmidt, Gudula, Caleo, Matteo, Costa, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998600/ https://www.ncbi.nlm.nih.gov/pubmed/33800135 http://dx.doi.org/10.3390/toxins13030194 |
Ejemplares similares
-
Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1)
por: Tantillo, Elena, et al.
Publicado: (2018) -
Voluntary Physical Exercise Reduces Motor Dysfunction and Hampers Tumor Cell Proliferation in a Mouse Model of Glioma
por: Tantillo, Elena, et al.
Publicado: (2020) -
Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages
por: Vannini, Eleonora, et al.
Publicado: (2017) -
The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model
por: Vannini, Eleonora, et al.
Publicado: (2014) -
Narrow and Broad γ Bands Process Complementary Visual Information in Mouse Primary Visual Cortex
por: Meneghetti, Nicolò, et al.
Publicado: (2021)